We help investors and international clients gain strategic advantage by unlocking the complexity of the evolving life science capex and infrastructure ecosystems, and connecting cross-border partnership in the U.S., China, and beyond.Across innovators, specialized service providers, and infrastructure partners, our role is to shorten the distance between scientific innovation and scalable execution. We are at the intersection of technology, capital, and operations, helping clients move from interest to action.

On-the-ground insight for trusted connections and smarter decisions
in an era of geopolitical and supply chain risk

We offer two complementary perspectives:U.S. Market Focus For companies exploring U.S. investment or partnerships, we deliver targeted analysis of pharmaceutical capital expenditure trends, actionable insights on who is investing, where, and why, and a clear view of key suppliers and emerging bottlenecks.China Partnership Focus For companies seeking collaborations in China, we provide unique intelligence on innovative biotech companies and the broader ecosystem of suppliers.

In an environment crowded with rising stars, we provide informed perspectives on which companies in China are truly positioned to scale, We conduct on-the-ground assessments to validate capabilities and readiness, particularly where distance, regulatory complexity, or information asymmetry create risk.Our due diligence is pragmatic, discreet, and tailored to the specific decision at hand. Our focus regions include Shanghai, Suzhou, the Greater Bay Area (Guangzhou, Shenzhen, Hong Kong, and Macau) and beyond.

Navigating cross-border business can be challenging with issues such as language, regulatory barriers and geographic distance or even subtle cultural nuances. You need a trusted on-the-ground partner to minimize costly missteps.We provide continuous relationship stewardship across regions and partners, helping clients strategically position themselves amid evolving geopolitical risks.Behind the scenes, we help build trust, maintain momentum, and turn opportunities into lasting, high-value collaborations.
Our mission is to bridge the gap between innovation and execution in an increasingly complex pharma global landscape. We deliver on-the-ground insights and trusted connections that help organizations reduce risk, move faster, and make better-informed decisions.
Managing Principal - Serena Chen: Bioscape Global is led by Serena Chen, an executive leader, industry advisor, and creative strategist partner. She brings deep expertise in business development, operations, the full capex ecosystems (EPCMQ firms, bioprocess suppliers, utility and automation vendors, and digital platforms), and unique access to both of the U.S. and China markets. She transforms technical barriers into quantitative, actionable strategies for international clients by demystifying opaque infrastructure ecosystems and navigating an evolving global landscape. She can be contacted directly at [email protected].Network: We draw on a trusted network of experts with deep technical knowledge across specialized domains. We help clients identify the right expertise to address specific challenges efficiently and effectively.

Bioscape Global engages selectively and collaboratively. Contact us at [email protected].